4/A//SEC Filing
KAVANAGH SARAH B 4/A
Accession 0001127602-18-016651
CIK 0000885590other
Filed
May 7, 8:00 PM ET
Accepted
May 8, 4:35 PM ET
Size
5.3 KB
Accession
0001127602-18-016651
Insider Transaction Report
Form 4/AAmended
KAVANAGH SARAH B
Director
Transactions
- Award
Common Stock, No Par Value
2018-05-03+13,881→ 53,745 total
Footnotes (2)
- [F1]Represents the award of restricted share units ("RSUs") granted to non-employee directors of Valeant Pharmaceuticals International, Inc. ("Valeant") on the third business day following their election at the Annual Meeting of Shareholders of Valeant (the "Annual Meeting"). The RSUs have a grant date value equal to $250,000, vest immediately prior to Valeant's next Annual Meeting, and are settled in common shares, no par value, of Valeant.
- [F2]This Amended Form 4 is being filed to correct the number of RSUs acquired on May 3, 2018 as reported on the Form 4 filed on May 4, 2018.
Documents
Issuer
Valeant Pharmaceuticals International, Inc.
CIK 0000885590
Entity typeother
Related Parties
1- filerCIK 0001681171
Filing Metadata
- Form type
- 4/A
- Filed
- May 7, 8:00 PM ET
- Accepted
- May 8, 4:35 PM ET
- Size
- 5.3 KB